Get the Stockscreener App
1.29
0.77%
-0.01
Casi Pharmaceuticals Inc stock is traded at $1.29, with a volume of 14,078.
It is down -0.77% in the last 24 hours and down -3.01% over the past month.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
See More
Previous Close:
$1.30
Open:
$1.29
24h Volume:
14,078
Relative Volume:
0.12
Market Cap:
$15.87M
Revenue:
$22.06M
Net Income/Loss:
$-30.94M
P/E Ratio:
-0.5759
EPS:
-2.24
Net Cash Flow:
$-26.70M
1W Performance:
-12.84%
1M Performance:
-3.01%
6M Performance:
-47.88%
1Y Performance:
-81.65%
1-Day Range:
$1.25
$1.355
1-Week Range:
$1.25
$1.77
52-Week Range:
$1.0909
$7.67
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
Name
Casi Pharmaceuticals Inc
Sector
Industry
Phone
-
Address
-
Compare CASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.29 | 20.14M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-21 | Initiated | BTIG Research | Buy |
| Apr-26-21 | Initiated | Mizuho | Buy |
| Oct-23-20 | Initiated | Oppenheimer | Outperform |
| Sep-22-16 | Initiated | Maxim Group | Buy |
| Oct-29-15 | Resumed | H.C. Wainwright | Buy |
| Jun-23-15 | Initiated | H.C. Wainwright | Buy |
View All
Casi Pharmaceuticals Inc Stock (CASI) Latest News
Is CASI Pharmaceuticals Inc. stock bottoming outFree Stable Entry High Return Opportunities - Newser
When is CASI Pharmaceuticals Inc. stock expected to show significant growthInvest smarter with high-probability setups - jammulinksnews.com
Why is CASI Pharmaceuticals Inc. stock attracting strong analyst attentionFree Predictions - jammulinksnews.com
Exit strategy if you’re trapped in CASI Pharmaceuticals Inc.Reversal Signal Prediction Based on Volume - Newser
Is CASI Pharmaceuticals Inc. stock overvalued or undervaluedHigh-yield market plays - jammulinksnews.com
How to manage a losing position in CASI Pharmaceuticals Inc.Fast Entry Strategy with Price Prediction - Newser
Using fundamentals and technicals on CASI Pharmaceuticals Inc.Smart Trend Analysis With Buy Point Cues - Newser
Pattern recognition hints at CASI Pharmaceuticals Inc. upsideFree Capital Efficiency Optimized Stock Alerts - Newser
Does CASI Pharmaceuticals Inc. fit your quant trading modelYearly Trend Summary and Opportunity Breakdown - Newser
Is CASI Pharmaceuticals Inc. still worth holding after the dipFree Entry Points For Growing Stocks - Newser
Should I hold or sell CASI Pharmaceuticals Inc. stock in 2025Market Forecast Tips With Proven Results - jammulinksnews.com
What makes CASI Pharmaceuticals Inc. stock price move sharplyPredictive System for Long-Term Stock Forecast - Newser
CASI Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Capital Preserving Trade Plan Templates - Newser
Is it time to cut losses on CASI Pharmaceuticals Inc.Pre-Market Stock Movement Summary and Review - Newser
What the charts say about CASI Pharmaceuticals Inc. todayPrice Action Summary and Entry Strategy Guide - Newser
How CASI Pharmaceuticals Inc. stock performs during market volatilityFree Secure Return Focused Investment Plan - Newser
How does CASI Pharmaceuticals Inc. generate profit in a changing economyFinancial News Planner Backed By Experts - jammulinksnews.com
Can you recover from losses in CASI Pharmaceuticals Inc.Free News Based Entry Opportunity Alerts - Newser
Advanced analytics toolkit walkthrough for CASI Pharmaceuticals Inc.Long-Term Stock Growth Forecast Insights - Newser
What are CASI Pharmaceuticals Inc. company’s key revenue driversChart Pattern Insights Backed By Experts - jammulinksnews.com
What is the dividend policy of CASI Pharmaceuticals Inc. stockWealth Building Picks That Work - jammulinksnews.com
What institutional investors are buying CASI Pharmaceuticals Inc. stockGrow your portfolio with growth-oriented stocks - jammulinksnews.com
What is the risk reward ratio of investing in CASI Pharmaceuticals Inc. stockBuild a diversified portfolio for sustainable growth - jammulinksnews.com
Does CASI Pharmaceuticals Inc. stock perform well during market downturnsTurn market volatility into profit opportunities - jammulinksnews.com
What are the technical indicators suggesting about CASI Pharmaceuticals Inc.Exceptional earning trajectories - jammulinksnews.com
Will CASI Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsTop Performing Low Risk Stocks - Newser
Casi Pharmaceuticals Inc Stock (CASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):